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The wild-type canine distemper virus (CDV) strain A75/17 induces a non-cytocidal infection in cultures of canine footpad keratinocytes
(CFKs) but produces very little progeny virus. After only three passages in CFKs, the virus produced 100-fold more progeny and induced a
limited cytopathic effect. Sequence analysis of the CFK-adapted virus revealed only three amino acid differences, of which one was located in
each the P/V/C, M and H proteins. In order to assess which amino acid changes were responsible for the increase of infectious virus production
and altered phenotype of infection, we generated a series of recombinant viruses. Their analysis showed that the altered P/V/C proteins were
responsible for the higher levels of virus progeny formation and that the amino acid change in the cytoplasmic tail of the H protein was the major
determinant of cytopathogenicity.
© 2006 Elsevier Inc. All rights reserved.Keywords: Canine distemper virus; Persistence; Cytopathic effect; Virus progenyIntroduction
Canine distemper virus (CDV) is a negative-strand RNA
virus which belongs to the Morbillivirus genus in the family
Paramyxoviridae. Infection with these agents still causes high
mortality epidemics in many different species, including
domestic dogs. CDV infection results in systemic disease
with involvement of the central nervous system and the
respiratory and gastrointestinal tracts (Alldinger et al., 1993).
Like measles virus (MV), canine distemper is associated with
profound short and long-term immune suppression, and much
of the mortality is caused by secondary infection (Cerruti-Sola
et al., 1983; Krakowka et al., 1980). Infection of the central
nervous system (CNS), which is a hallmark of distemper, is
characterized by virus persistence and massive demyelination
(Vandevelde et al., 1995). Persistence of virus in the CNS and⁎ Corresponding author. Fax: +41 21 692 41 25.
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doi:10.1016/j.virol.2006.07.054in foot and nose pads leads to diseases known as old dog
encephalitis and hard pad disease (Appel, 1969). Immunohis-
tochemistry of footpads of naturally infected dogs showed the
presence of virus and it was possible to use biopsies of
footpads as a means of ante mortem diagnosis of infection
(Haines et al., 1999).
A75/17 CDV, a virulent wild-type strain was isolated from a
dog with spontaneous distemper and may be considered the
prototype virulent CDV. In Dog Brain Cell Culture (DBCC) this
virus produces a non-cytolytic, persistent infection with very
selective virus spread (Zurbriggen et al., 1995) characteristic of
the in vivo situation in the CNS (Vandevelde et al., 1985). The
virus cannot be grown in cell lines unless it is adapted by many
weeks of blind passaging (Hamburger et al., 1991). Alter-
natively, the virus may be propagated in cells expressing the dog
SLAM receptor (Plattet et al., 2005; Seki et al., 2003; Tatsuo
and Yanagi, 2002; Yanagi et al., 2002).
Examination of footpads of experimentally infected dogs
showed that A75/17 establishes a non-cytocidal infection and
7J.-P. Rivals et al. / Virology 359 (2007) 6–18induces cell proliferation (Engelhardt et al., 2005; Grone et al.,
2003a, 2003b, 2004a, 2004b). The same phenotype of infection
was observed in primary cultures of canine footpad keratino-
cytes (CFKs) with virus isolated from lymphoid tissue of
infected dogs that had not been passaged in cell culture
(Engelhardt et al., 2005). This observation suggested that CFKsFig. 1. Infection of canine footpad keratinocytes. (A) CFKs were infected with A75/
infection (dpi) by staining with anti-CDV N protein Mab, followed by FITC-conj
Percentage of infected cells and number of syncytia observed at 1, 3 and 5 dpi. (C) G
Cells were infected at an moi of 0.00025 with the both viruses. Virus titers were determ
by immunocytochemistry. Mean values of infected cells± the standard errors of the me
into the cell culture medium, ●; cell-associated virus.might be the cells of choice to study determinants of virus
persistence.
In this study we have investigated the growth properties and
phenotype of infection of A75/17 in CFKs. We found that A75/
17 infects these cells readily but produces very little virus
progeny. In contrast, after only 3 passages in CFKs, we were17 and A75/17-K at an moi of 0.00025 and observed after 1, 3 and 5 days post
ugated-labeled anti-mouse IgG. Representative fields of view are shown. (B)
rowth kinetics of A75/17 and A75/17-K viruses in canine footpad keratinocytes.
ined at the indicated times post infection by counting infected cells after staining
ans from two experiments in triplicate are shown.■; Infectious progeny released
Table 1
Comparison of nucleotide and deduced amino acid sequences between A75/17
and A75/17-K CDV
Gene Nucleotide Amino acid
Position a A75/
17
A75/
17-K
Ratio b Protein Position c A75/
17
A75/
17-K
P/V/C 2240 G A 8/10 P 147 Ser Asn
P/V/C 2240 G A 8/10 V 147 Ser Asn
P/V/C 2240 G A 8/10 C 140 Ala Thr
M 3528 C T 6/10 M 33 Pro Ser
M 4302 T C 8/10 M 291 d Leu Leu
H 7146 T C 8/10 H 23 Leu Pro
H 7151 T C 8/10 H 25d Leu Leu
a Nucleotide position in the entire genome.
b Mutated clones by 10 independent cDNA clones.
c Amino acid position in each protein.
d Silent mutation.
8 J.-P. Rivals et al. / Virology 359 (2007) 6–18able to isolate a virus which yielded 100 times more progeny
and induced limited syncytia formation. We show that these
properties are due to only 3 amino acid changes. The
contribution of each of these amino acid changes in determining
the phenotype of infection and yield of progeny virus was
examined in detail.
Results
Comparison of A75/17 and A75/17-K viruses in canine footpad
keratinocytes
Examination of footpads of experimentally infected dogs
showed that A75/17 produces a persistent infection without
syncytia formation and absence of inclusion bodies (Grone
et al., 2003b). Moreover, it has recently been reported that
A75/17 can infect cultures of canine footpad keratinocytes
without the need of prior adaptation of the virus to these cells
(Engelhardt et al., 2005). We therefore decided to investigate
A75/17 infection of CFKs in more detail. To our surprise, initial
titration experiments showed that CDV infected CFKs yielded
very little progeny virus. We therefore passaged A75/17 3 times
in CFKs and designated the resulting virus A75/17-K. We then
performed a detailed characterization of the growth properties
and phenotype of infection of A75/17 and A75/17-K in CFKs.
Cell-to-cell fusion, the extent of which varied between the
two viruses, was the most obvious cytopathic effect (CPE)
observed in infected CFKs. We therefore categorized both
viruses, as well as the rCDVs generated in this study, according
to their fusion-inducing capabilities. As expected, the pheno-
type of infection of A75/17 in CFKs was mainly non-fusogenic
with only very rare and small syncytia produced 5 days post
infection (dpi) (Figs. 1A and B). In contrast, A75/17-K induced
significantly more and larger syncytia, which were already seen
3 dpi (Figs. 1A and B). Moreover, at these time points, the
percentage of infected cells was higher for A75/17-K than for
A75/17 (Fig. 1B). This suggests that A75/17-K either replicates
more rapidly in CFKs, or spreads to neighboring cells more
efficiently than A75/17, or both. This observation prompted us
to analyze the growth kinetics of A75/17 and A75/17-K viruses
in CFKs. Whereas very little cell-free and cell-associated virus
was detected from cells infected with A75/17, A75/17-K
efficiently produced both cell-free and cell-associated virus,
typically reaching 0,5×104/ml of cell-associated infectious
virus 3–5 days after infection (Fig. 1C). Thus, the results showed
that the capacity of A75/17-K to efficiently disseminate in CFKs
is associated with an increase in infectious virus production.
In addition, spread of A75/17 in CFKs, which is quite
efficient, although slower than spread of A75/17-K (Fig. 1A),
does not appear to require the production of large amounts of
infectious progeny virus.
Nucleotide sequence comparison between A75/17 and
A75/17-K
To characterize the genetic differences that account for the
increase in virus progeny formation, syncytia formation andmore efficient spread of A75/17-K, we sequenced the entire
genomes of the A75/17 and A75/17-K viruses. Comparison of
the two genomes revealed that the total length of 15,960
nucleotides and the overall organization were identical. Only
five nucleotide differences were found. Two of these were silent
but three resulted in amino acid changes in the P, V and C
proteins, in the M protein as well as in the H protein (Table 1).
Other genome regions including the leader, trailer, transcription
start and stops signals, intergenic sequences and non-coding
regions of all six genes remained unchanged between the two
viruses.
Upon sequencing of the genomes we observed the described
differences in the A75/17-K virus. However, at the same
position in the electrophoregrams, a second less prominent peak
corresponding to the nucleotide of the A75/17 sequence was
also seen, suggesting heterogeneity in the virus population. We
therefore cloned cDNA copies of the A75/17-K virus,
encompassing the region where the sequences differed between
the A75/17 and A75/17-K virus. For each region we sequenced
10 independent cDNA clones and determined the frequency of
occurrence of the particular nucleotide differing from the
sequence of the A75/17 virus at the given position (Table 1).
The analysis showed that the virus obtained after three passages
in CFKs indeed represents a heterogeneous virus population.
Recovery and characterization of recombinant viruses
Since the virus population after 3 passages in CFKs was not
pure and since we wanted to study the effects of individual
nucleotide changes and all possible combinations of the three
nucleotide differences between the A75/17 and A75/17-K virus,
we decided to construct recombinant viruses. As a first step we
rescued the wild-type virus from cloned cDNA using the
plasmid pA75/17-V3 containing the full-length cDNA of the
Vero cell-adapted virus, in which the individual viral genes are
separated by engineered restriction sites (Plattet et al., 2004).
This allowed replacing the genes that differ between the Vero
cell-adapted virus and the A75/17 virus by those of the A75/17
virus. Recombinant virus was then generated as described
previously (Plattet et al., 2004), with minor modifications (see
Fig. 2. Schematic representation of the genome of rA75/17 and recombinant
chimeric viruses. The black boxes represent genes of the A75/17-K virus.
9J.-P. Rivals et al. / Virology 359 (2007) 6–18Materials and methods). The rescued rA75/17 virus was
characterized and sequenced and no differences were observed
with respect to the parental virus (data not shown).
In order to determine which nucleotide difference is
important for viral particle production, recombinant viruses
containing one, two or three nucleotide substitutions were
generated. The plasmid pA75/17 containing the full-length
cDNA of the A75/17 virus was used to introduce theFig. 3. Infection of canine footpad keratinocytes with recombinant viruses. CFKs we
post infection by phase contrast microscopy (A–H) or by fluorescence microscopy aft
anti-mouse IgG (A′–H′). Representative fields of view are shown.nucleotide changes characteristic of the A75/17-K virus by
site-directed mutagenesis. Recombinant viruses were then
generated. The structure and designation of recombinant
viruses are show in Fig. 2A. In all viruses, insertion of the
gene corresponding to the A75/17-K virus and absence of
other mutations were confirmed by sequencing (data not
shown).
Infection of CFK by rCDVs
We next examined the phenotype of infection of the
recombinant viruses in CFKs. The recombinant wild-type
rA75/17 virus was characterized by a very limited fusogenicity,
consistent with the phenotype of infection induced by the
parental A75/17 virus. Infection with the recombinant viruses
rA75/17-Pk, rA75/17-Mk and rA75/17-Pk-Mk produced
slightly more syncytia than the wild-type virus but clearly less
than the Hk-bearing recombinant viruses. Indeed, these latter
viruses showed a highly fusogenic phenotype of infection at 5
dpi, as revealed both by phase contrast microscopy and
immunofluorescence staining (Fig. 3). These results werere infected with an moi of 0.001 of recombinant viruses and observed at 5 days
er staining with anti-CDV N protein Mab, followed by FITC-conjugated-labeled
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syncytia induced by each virus in the entire cell monolayer
(Table 2). Taken together, these results demonstrate that
recombinant viruses bearing the H protein of the CFK-adapted
virus gained the ability to induce efficient cell-to-cell fusion.
Furthermore, the recombinant viruses harboring the Hk gene
together with the Pk gene produced even more extensive
syncytia (Table 2). Interestingly, the percentage of infected cells
obtained with rA75/17-Mk was similar to that obtained with
rA75/17 and lower than with the other recombinant viruses
(Table 2) suggesting that the mutation in the M gene does not
have a major impact on virus dissemination.
Growth kinetics of recombinant viruses in CFKs
Since the A75/17-K virus spreads more rapidly in CFKs than
the A75/17 parent virus, we compared the growth kinetics of the
recombinant viruses to determine the role of each amino acid
difference in mediating this difference in the phenotype of
infection in CFKs (Fig. 4). The results showed that all
recombinant viruses reached a plateau of infectious progeny
at 3 dpi. Note that in this experiment the yield of infectious virus
obtained with rA75/17 and rA75/17-Pk-Mk-Hk was higher than
the yield of infectious virus obtained with the parental A75/17
and A75/17-K (see Fig. 1). This could be in part due to the fact
that a higher moi was used. In addition, the growth properties of
molecularly cloned viruses may be different from those of the
parental A75/17 and A75/17-K viruses, which represent a
heterogeneous virus population. Furthermore, the A75/17 virus
stock used in this study was a homogenate of lymphoid tissuesTable 2
Determination of percentage of infected cells and number of syncytia
Strain dpi % cells
infected
Number of syncytia
3–5
nuclei
6–20
nuclei
21–50
nuclei
>50
nuclei
rA75/17 1 1 0 0 0 0
3 12 8 0 0 0
5 32 60 28 1 0
rA75/17-Pk 1 1 0 0 0 0
3 20 18 4 0 0
5 63 100 52 4 2
rA75/17-Mk 1 1 0 0 0 0
3 14 20 7 0 0
5 35 82 39 6 2
rA75/17-Hk 1 1 0 0 0 0
3 23 40 12 4 1
5 67 220 465 59 29
rA75/17-Pk-Mk 1 1 0 0 0 0
3 19 25 5 0 0
5 53 110 65 5 3
rA75/17-Pk-Hk 1 1 0 0 0 0
3 19 15 35 1 1
5 65 60 443 177 159
rA75/17-Mk-Hk 1 1 0 0 0 0
3 21 30 10 1 0
5 72 200 353 44 14
rA75/17-Pk-Mk-Hk 1 1 0 0 0 0
3 20 20 40 1 1
5 68 205 512 166 105of infected dogs and may contain interferons and/or other
cytokines, which could modulate virus replication.
Recombinant viruses rA75/17, rA75/17-Mk and rA75/17-
Pk-Mk showed similar growth kinetics (Figs. 4A, C, E).
Recombinants viruses bearing the H gene of the A75/17-K virus
also had similar growth properties but the yield of infectious
progeny was higher than those obtained with the former viruses
(Figs. 4D, F, G and H). Interestingly, the recombinant virus
expressing the P protein of the CFK-adapted virus produced
over 10-fold higher levels of progeny virus than the recombi-
nant rA75/17 virus (Fig. 4B).
Functional comparisons between the A75/17 and A75/17-K
envelope glycoproteins
Cell-to-cell fusion in paramyxoviruses requires the coex-
pression of the F protein and the receptor-binding H protein
(Lamb, 1993; Lamb and Kolakofsky, 2001). Nucleotide sequen-
cing revealed no differences in either the coding or non-coding
region of the F gene but identified two nucleotide changes loca-
ted both in the cytoplasmic tail of the H protein (see Table 1).
While one nucleotide difference was silent (L25L), the second
one changed the leucine at position 23 into a proline (L23P).
Since the A75/17 and A75/17-K viruses exhibited different
fusogenic properties, we determined whether the H proteins of
the 2 viruses, abbreviated Hwt and Hk, respectively, had
different fusion-promoting characteristics. The mutation L23P
was introduced by site-directed mutagenesis in the wild-type H
expression plasmid (Plattet et al., 2005) and cell-to-cell fusion
was analyzed using a transient expression system. Both H genes
were cotransfected with the A75/17 F gene (which is identical in
A75/17 and A75/17-K strains) in CFKs. No syncytia were
observed in transfection experiments with the Hwt gene. This
was not due to problems of production or targeting of Hwt,
since cotransfection experiments of Hwt with Fop showed
syncytia formation in CFKs (data no shown). In contrast,
syncytia were readily observed when the Hk gene was used for
transfection (Fig. 5A). Interestingly, in Vero cells, and in
agreement with our previous observations, combinations
including Hwt also never showed any CPE, but few syncytia
were repeatedly observed when Hk was expressed in combina-
tion with the highly fusogenic F protein of the Onderstepoort
CDV vaccine strain (data no shown). Thus, the transfection
experiments strongly suggest that the higher fusogenic activity
of the A75/17-K virus is due to the L23P difference in the
cytoplasmic tail of Hk. In order to rule out the possibility that
the observed differences in fusogenicity were due to different
expression levels of the H proteins, Western blotting was
performed using cellular actin as an internal control (Fig. 5B).
The result showed that both proteins were expressed to similar
levels, demonstrating that the L23P mutation does not affect the
stability of the protein.
Efficiency of entry of rCDVs in CFK
We reasoned that the more rapid spread of A75/17-K virus in
CFKs might not only be due to more virus progeny formation
Fig. 4. Growth kinetics of recombinant viruses in canine footpad keratinocytes. Cells were infected at an moi of 0.001 of the different recombinant viruses. At the
indicated days post infection, extracellular and cell-associated virus was harvested and titrated. Virus titers were determined by counting the number of virus infected
cells after staining of the monolayer by immunocytochemistry using the CDVanti-N protein Mab. Mean values of infected cells± the standard errors of the means from
two experiments in triplicate are shown. □; Infectious progeny released into the cell culture medium, ○; cell-associated virus.
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this possibility we infected CFKs with an moi of 0.001 of the
different recombinant viruses that previously had been titrated
in CHO.DogSLAMtag cells. These cells constitutively express
the dog SLAM molecule and thus can readily be infected with
both CDV field and vaccine strains (Plattet et al., 2005; Seki
et al., 2003; Tatsuo and Yanagi, 2002). One day post infection,
immunohistochemistry of infected CFKs was performed and
stained cells were counted. The number of infected CHO.
DogSLAMtag cells was arbitrarily set at 100% (Fig. 5C). As
expected, CHO.DogSLAMtag cells, expressing the naturalCDV receptor yielded much higher numbers of infected cells
than CFKs, which do not express detectable amounts of the
SLAM receptor (unpublished observation). More importantly,
no significant differences in cell entry efficiency were found
between viruses bearing the A75/17H protein or the A75/17-
KH protein.
Mutation in P gene influences polymerase activity
We considered the possibility that the amino acid change in
the P protein (S147N), in the V protein (S147N) and in the C
Fig. 5. Formation of syncytia in CFKs transfected with expression plasmids
encodingH and F proteins. (A) CFKswere cotransfected with plasmids encoding
the F protein of the A75/17 virus (Fwt) and either the H protein of the A75/17
virus (Hwt) or the H protein of the A75/17-K virus (Hk). At 24 h post infection
cells were examined by phase contrast microscopy. Representative fields of view
are shown. (B) Total proteins were extracted from CFKs transfected with
plasmids encoding the F proteins and either the Hwt or Hk protein, separated by
reducing SDS-PAGE and blotted onto nitrocellulose membranes. Blots were
probed with an anti-H antiserum and an anti-actin. (C) Cell entry efficiency of
recombinant viruses. CFKs were infected with an moi of 0.001 of the different
recombinant viruses that previously had been titrated in CHO.DogSLAMtag
cells. At 24 h post infection cells were fixed and stained by immunocytochem-
istry. The number of infected cells in 3 wells of a 6-well plate was counted. The
bar graph shows the percentage of cells infected by the indicated recombinant
viruses with respect to the number of infected CHO.DogSLAMtag cells, which
was arbitrarily set at 100% (a). Mean values of infected cells± the standard errors
of the means from three experiments are shown.
Fig. 6. (A) Relative activities of A75/17 (■) and A75/17-K (□) polymerase with
different amounts of L protein expression plasmid. CFKs were transfected with
N, P and L encoding expression plasmids and a minireplicon encoding plasmid
harboring the CAT gene. CAT concentrations were determined by ELISA (see
Materials and methods). (B) Polymerase activity of A75/17 and A75/17-K. CFK
cells were infected with the recombinant vaccinia virus MVA-T7 at an moi of
1.5, and transfected with plasmids encoding the N, a minireplicon encoding
plasmid harboring the CAT gene and either the P gene of the A75/17 or A75/17-K
virus, represent the negative control of polymerase without the expression
plasmid encoding the L protein (white bars). Transfections were also performed
with the above plasmids together with expression plasmids encoding the L
protein (black bars). At 24 h after transfection, cells were lysed and CAT
concentrations were determined by ELISA. Mean values of transfected cells±
the standard errors of the means from six experiments in triplicate are shown.
(C) Western blots were done on the four different cell lysates after quantification
of the total proteins by Bradford and migration on SDS PAGE (10%
acrylamide). Immunodetection was made with an anti-N D110 monoclonal
antibody, an anti-P mouse monoclonal 4.415 antibody and an anti-β-tubulin
monoclonal antibody.
12 J.-P. Rivals et al. / Virology 359 (2007) 6–18protein (A140T), influences polymerase activity, which could
also effect progeny virus formation. In order to investigate
this possibility, a minireplicon assay was used to compare thepolymerase activities of A75/17 and A75/17-K in CFKs
(Figs. 6A and B). In this assay, the peGFP/CAT (+) plasmid
was transfected together with plasmids coding the N, P and L
proteins. Different amounts of the L protein expression
plasmid were used to rule out that possible differences in
polymerase activities of the 2 viruses were not affected by the
amount of L protein expressed. The negative controls
consisted of transfection experiments in which the plasmid
encoding the L protein was omitted, which showed that CAT
13J.-P. Rivals et al. / Virology 359 (2007) 6–18expression from the minireplicon plasmid depended on the
expression of a functional CDV polymerase (data not shown).
As expected, CAT concentrations varied according to the
amount of transfected L expression plasmid, with 50 ng of
transfected L expression plasmid yielding the highest concen-
trations of CAT. More importantly, transfection experiments
with the Pk expression plasmid consistently gave higher CAT
concentrations than transfections with the Pwt plasmid with all
different amounts of L expression plasmid tested (Figs. 6A and
B). In order to rule out the possibility that the observed
differences in polymerase activity were due to different
expression levels of the N and P proteins, Western blotting
was performed using cellular tubulin as an internal control
(Fig. 6C). The expression level of the L protein was not
determined since no anti-L antibody was available to us. The
results showed that the N and P proteins were expressed in
similar amounts in transfected cells. Thus, the differences in
RNA polymerase activity between the wild-type and the adapted
virus are not due to different levels of protein expression but
represent true properties of the corresponding viral enzymes.
Discussion
Recently, it has been shown that primary canine footpad
keratinocytes were susceptible to A75/17 infection, the
prototype wild-type CDV strain (Engelhardt et al., 2005). In
these cells the virus produces a non-cytolytic phenotype of
infection, closely mimicking the situation observed in footpads
of infected animals. However, when we attempted to titrate the
virus progeny obtained from infected CFKs, we were surprised
to find that very little infectious virus was produced, despite the
fact that a large number of cells were infected. Interestingly,
only 3 passages in CFKs were sufficient to select for a virus
variant, which spread more rapidly in the cell monolayer,
produced much more progeny and induced limited CPE. We
reasoned that by comparing the CFK-adapted virus to the
parental virus, we would learn more about determinants of
persistence in CDV.
Sequencing of the genome of the CFK-adapted virus
revealed that the new phenotype was associated with amino
acid changes in the P protein, which also affected the V and C
proteins, and in the M and H proteins. In order to investigate the
roles of each of these amino acids differences in producing the
new phenotype of infection in the A75/17-K virus, we
introduced the corresponding nucleotide changes into a cDNA
clone of the A75/17 virus and generated recombinant viruses by
reverse genetics technology. These recombinant viruses allowed
us to study the contribution of each amino acid change in
mediating the new phenotype of infection of the CFK-adapted
virus.
It is well known that the M protein is a central player in virus
assembly and release (Lamb and Kolakofsky, 2001). Surpris-
ingly, rA75/17-Mk and rA75/17-Pk-Mk viruses were character-
ized by a wild-type-like phenotype, inducing very rare and
small syncytia with only limited virus production, which barely
exceeded 1×103 and 1×102 of cell-associated and cell-free
infectious virus/ml, respectively. P33 in the M protein is highlyconserved in the Morbillivirus genus and it is not clear why
such a major amino acid change (P33S) does not have more
drastic consequences. Interestingly, the growth advantage of
recombinant viruses expressing the Pk protein (see below) is
lost in recombinant viruses also expressing the Mk protein. It
has been reported that viral persistence is associated with a
defect in M protein production, or stability (Billeter et al.,
1994). Whether or not the P33S substitution in the M protein
affects the persistent nature of infection in the CNS of dogs
merits future investigations.
The amino acid changes in the P, V and C proteins, as well
as the H protein, had a major impact on the phenotype of
infection. All recombinant viruses bearing the wild-type H
protein with the L23P mutation in the cytoplasmic tail (CT)
were characterized by an increase in virus production as well
as in fusogenicity, which in turn may lead to a more efficient
virus spread. This demonstrates a crucial role of H protein CT
domain in mediating cell-to-cell fusion. The CDV H protein
binds to a cellular receptor thus determining viral tissue
tropism (Stern et al., 1995; von Messling et al., 2001) and
modulates the extent of cell-to-cell fusion by interacting
directly with the F protein (Lamb and Kolakofsky, 2001;
Melanson and Iorio, 2006; Plemper et al., 2001). Recent
studies showed that a single amino acid substitution in the
measles virus H CT domain lead to a retargeting of the
glycoprotein from the basolateral to the apical membrane in
MDCK polarized cells (Moll et al., 2001, 2004). Moreover,
deletion mutants in this subdomain showed differences in
syncytia formation (Cathomen et al., 1998b; Moll et al., 2002).
Our transient expression experiments are in agreement with the
involvement of the CT domain in fusogenicity, since the L23P
change in the wild-type H protein was sufficient to mediate
cell-to-cell fusion. Three main hypotheses of how the CT
domain controls fusogenicity can be considered. First, the
L23P change could induce a major conformational alteration in
the H protein, modulating the receptor-binding site. Indeed,
H23 is conserved as L, I or V in morbilliviruses and a change
to P is expected to affect protein folding, which could result in
an enhanced affinity between H protein and the cell surface
receptor thus triggering an efficient signal transduction to the F
protein. Secondly, the modified CT domain could transmit a
more limited signal, modulating only a subdomain in H. Our
results of cell entry efficiency obtained with the different
rCDVs, showing no significant differences between the
recombinant viruses argues in favor of this latter hypothesis.
This suggests that the L23P substitution controls an “inside-
out” modification in the stalk region of the H ectodomain,
which is thought to interact with F (Lawrence et al., 2004;
Melanson and Iorio, 2006). This could affect the interaction
with F, without affecting the receptor-binding site located in
the head in the 3D structure of the H protein. Finally, the L23P
change might simply target the H protein more efficiently to
the cell surface, thus allowing efficient fusion to occur. This
could explain the efficient virus release observed with rCDVs
bearing Hk. In this context it is interesting to note that the MV
F and H CT domains have been shown to be involved in virus
assembly (Cathomen et al., 1998a). Further studies are needed
14 J.-P. Rivals et al. / Virology 359 (2007) 6–18in order to better understand the function of the H L23P
substitution in both virus production and fusogenicity.
The P protein of paramyxoviruses plays multiple roles in both
transcription and replication, being an indispensable subunit of
the viral RNA-dependent RNA polymerase complex (Curran,
1996; Curran et al., 1992). In our study, the S147N and/or the
A140Tsubstitution in the P/Vand C proteins respectively, confer
to the A75/17-K virus a significantly increased capability of
producing progeny virus. How can the P gene control virus
production? Our minireplicon assay showed an increase in RNA
synthesis in the presence of P protein bearing the S147N
substitution as compared to the wild-type protein. Interestingly,
this mutation is located outside an element important for
replication activity (aa 33 to 41, with respect to the numbering of
the P protein of Sendai virus—SeV) in the so-called PNT
domain of the P protein. In fact, amino acids 78–320 have been
shown to be dispensable for RNA synthesis (Curran et al., 1994).
It has been suggested that this subdomain can be deleted because
this segment in MV (and probably all paramyxoviruses) is
intrinsically unstructured (Karlin et al., 2002). Nevertheless, in
our case, RNA synthesis was affected by the nucleotide
substitution in the P gene. Based on the hypothesis that the
amount of viral proteins regulates particle formation and
budding, the efficient viral replication associated with this
amino acid substitution would in turn increase the amount of
viral proteins synthesized in infected cells. This would obviously
lead to an increase in virus dissemination.
However, since the mutation in the P protein also affects the
V and C open reading frame, we cannot rule out that the
observed effect is due to the amino acid substitution in the V
and/or C proteins. Indeed, both proteins of SeV and MV inhibit
RNA synthesis (Cadd et al., 1996; Curran et al., 1991, 1992;
Horikami et al., 1996, 1997; Kato et al., 2004; Parks et al., 2006;
Reutter et al., 2001; Tober et al., 1998; Witko et al., 2006).
It has recently also been shown that the C protein of SeV
plays a positive role in virus-like particle formation (Sakaguchi
et al., 2005; Sugahara et al., 2004). In addition, the SeVand MV
V and C proteins have been shown to inhibit induction and
response of IFN-α/β (Didcock et al., 1999; Gotoh et al., 1999;
Palosaari et al., 2003; Shaffer et al., 2003; Takeuchi et al.,
2003a; Yokota et al., 2003). Thus, any differences in the IFN
antagonism function could also affect the phenotype of
infection. In order to better understand the role of the V and C
proteins we are currently producing recombinant C and V
knockout mutants as well as mutants expressing these proteins
from an additional transcription unit. Moreover, we are testing
in CFKs the effect of IFN on RNA synthesis using our
minireplicon assay.
The receptor that CDV uses to infect CFK is unknown. At
the present time, the only known receptor for CDV is SLAM, a
molecule restricted to activated T and B lymphocytes, immature
thymocytes, mature dendritic cells and activated monocytes
(Cocks et al., 1995). All our attempts to detect the presence of
SLAM in CFKs failed. Therefore, it appears that CDV uses an
alternative receptor. Interestingly, this receptor does not allow
the A75/17 virus to induce syncytia. This suggests that the
affinity of the H protein of the A75/17 virus to this non-identified receptor is low, which could explain the non-
fusogenic phenotype of infection of the A75/17 virus in
CFKs. In MV there is growing evidence for the presence of
other receptors, besides CD46 and SLAM (Andres et al., 2003;
Hashimoto et al., 2002; Takeuchi et al., 2003b). The identifica-
tion of non-SLAM receptors for wild-type CDV in footpad
keratinocytes and other tissues may be an important step
towards understanding the primary infection route and spread of
the virus.
Analysis of the genome of the A75/17-K virus showed that
the nucleotide differences between the A75/17 and A75/17-K
virus, resulting in amino acid changes, were not completely
fixed, as demonstrated by the sequencing of 10 cDNA clones
obtained from infected cells. Whether the differences in the
A75/17-K virus are due to pre-existing quasi-species, which are
selected for during passage in CFKs, or to mutations appearing
during passages, requires further investigations. The genomes
of RNA viruses are known to be heterogeneous (Domingo,
1992; Evermann et al., 2001; Steinhauer et al., 1989), and it was
proposed that the heterogeneity contributes to the efficient
infection of multiples tissues (Baranowski et al., 2001;
Morimoto et al., 1998). In this context it will be interesting to
sequence the genomes of CDV isolated directly from footpad
keratinocytes of experimentally infected dogs to test whether
virus variants, which are capable of replicating to high titers in
these cells are also selected for in vivo.
Materials and methods
Cell culture and virus
Canine footpad keratinocytes were cultured as described
(Engelhardt et al., 2005). Cells are maintained in William's E
medium (Bioconcept, Allschwil, CH) including antibiotic/
antimytotic solution (Gibco BRL, Basel, CH), 10% fetal bovine
serum, L-glutamine 2 mM (Bioconcept, Allschwil, CH),
10−10 M cholera toxin (Sigma, Buchs, CH), and 10 ng/ml of
epidermal growth factor EGF (Sigma). Cell cultures were
incubated at 35 °C in 5% CO2. When the monolayer was
confluent, cells were detached with trypsin (5× trypsin/EDTA
PBS, Gibco) and seeded into new culture dishes.
CHO.dogSLAMtag cells were maintained in DMEM/NUT.
MIX: F12 (Gibco) supplemented with 10% FBS, 1× hypo-
xanthine (Gibco) and 0.5 mg/ml of G418 (Promega).
The wild-type canine distemper virus, designated A75/17
CDV was obtained from M. Appel, Cornell University, Ithaca,
NY. The virus was grown in experimentally infected dogs. A
homogenate of lymphoid organs was used for infection of
cultured cell lines. The canine footpad keratinocyte-adapted
CDV, designed A75/17-K, was obtained after 3 passages of the
wild-type virus in canine footpad keratinocytes.
Titration and infection of viruses
Titration of viruses was performed in CHO.dogSLAMtag
cells. Cells were infected for 24 h with different dilutions of
viruses. After staining for immunocytochemistry, syncytia were
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different viruses at the moi indicated in the figure legends. After
1 h of incubation at 35 °C the viruses were removed and the
cells were incubated for different time points in medium
containing 5% FBS.
Immunocytochemistry and immunofluorescence
Cells were fixed with ethanol:acetic acid (95:5) and blocked
with 5% goat serum. Viral antigen was demonstrated using the
D110 anti-N monoclonal antibody (Hamburger et al., 1991).
Cells were incubated with unlabeled antibody peroxidase–
antiperoxidase (PAP) method (Sternberger, 1979) or with
fluorescein isocyanate-conjugated goat anti-mouse immunoglo-
bulin G (Sigma) and examined by fluorescence microscopy.
Growth kinetics
To determine growth kinetics, the supernatant of infected
cells was collected and stored at −70 °C. Cell-associated viruses
were recovered by scraping the cells into 1 ml of Opti-MEM
(Gibco) followed by two cycles of freeze–thaw. Cell debris
were removed by centrifugation at 2500 rpm for 8 min at 4 °C,
and the supernatant was stored at −70 °C. For titration, different
dilutions of supernatant and cell-associated viruses were used to
infect CHO.dogSLAMtag cells and virus titers were determined
by immunocytochemistry, as described above.
Sequencing of the A75/17-K virus
Total RNA was extracted from A75/17-K infected canine
footpad keratinocytes using the Rneasy kit (Qiagen). Regions
spanning all genes were then reverse transcribed from viral
genomic RNA using Superscript II (Invitrogen) reverse
transcriptase (RT) and random primers. PCR amplification
was performed using the Pfu polymerase (Promega) with
specific primers. From these PCR products, sequences were
determined using the BigDye 3.1 cycle sequencing kit (Perkin
Elmer). The sequencing reactions were run on an ABI 3730
automated sequencer.
Construction of plasmids
The A75/17 F and H genes were cloned into the pCI vector
(Promega) (Plattet et al., 2005). The sequence of the cloned H
gene of A75/17 was changed into the sequence of A75/17-K by
site-directed mutagenesis using the Quick Change Site-Directed
Mutagenesis kit (Stratagene). These plasmids were designed
pCI-Fwt, pCI-Hwt, pCI-Fop and pCI-Hk.
The minireplicon plasmid, designated peGFP/CAT (+),
containing the eGFP and the CAT genes was constructed using
standard methods (Maniatis, 1982). It contains at the 5′ side of
the GFP reporter gene the CDV genome promoter and at the 3′
end of the CAT gene the CDV antigenome promoter. The
construct also contains a T7 promoter at the 5′ end and a T7
terminator downstream of the hepatitis delta virus ribozyme
sequence (Sidhu et al., 1995) at the 3′ end. The genes encodingthe N, P, C and L proteins of A75/17 were cloned into pTM-1
vector. In this vector, the genes are expressed under the control of
the T7 promoter and the resulting RNA has an IRES sequence
allowing internal ribosome entry. The sequence of the cloned P
and C of A75/17 was changed into the sequence of A75/17-K by
site-directed mutagenesis using the Quick Change Site-Directed
Mutagenesis kit (Stratagene). These plasmids were designated
pTM-N, pTM-PA75/17, pTM-PA75/17-K, and pTM-LA75/17.
Generation of recombinant CDV viruses
Plasmid pA75/17-V3 carrying the full-length cDNA genome
of A75/17-V has been described previously (Plattet et al., 2004).
This plasmid has been modified in order to obtain the full-length
cDNA genome of A75/17. The sequence of P and L genes of
A75/17-V was changed into the sequence of A75/17 by site-
directed mutagenesis using the Quick Change Site-Directed
Mutagenesis kit (Stratagene). The A75/17 M gene was excised
from pGEM-T easy (Promega) construct and ligated to PmeI-
MluI cleaved pA75/17-V3, resulting in plasmid pA75/17.
The sequence of P, M and H genes of A75/17 was changed
into the sequence of A75/17-K by site-directed mutagenesis
using the Quick Change Site-Directed Mutagenesis kit
(Stratagene), resulting in plasmids pA75/17-Pk, pA75/17-Mk,
and pA75/17-Hk respectively. The fragment containing the Pk
gene was excised from pA75/17-Pk and ligated to NotI-PmeI
cleaved pA75/17-Mk and pA75/17-Hk, resulting in plasmid
pA75/17-Pk-Mk and pA75/17-Pk-Hk respectively. The frag-
ment containing the Hk gene was excised from pA75/17-Hk
and ligated to MluI-BssHII cleaved pA75/17-Mk and pA75/17-
Pk-Mk, resulting in plasmid pA75/17-Mk-Hk and pA75/17-Pk-
Mk-Hk respectively.
Recovery, propagation and titration of recombinant CDV
viruses
Recombinants viruses were recovered as described by Plattet
et al. (2004). Bsr-T7 cells at a confluency of 50% were
transfected with N, P and L expression vectors together with a
plasmid containing a DNA copy of the relevant CDV genome.
After 2 days, the transfected cells were trypsinized and co-
cultured during 3–5 days with fresh Vero-dogSLAMtag cells at
a confluence of 80%. For each virus, three syncytia were
isolated and incubated with fresh Vero-dogSLAMtag cells in 6-
well plates. The infected cells were expanded in 10-cm Petri
dishes. After 3 or 5 days, the culture medium was replaced by
2 ml of Opti-MEM (Gibco) and the cells were harvested and
lysed by freeze–thaw. The cleared supernatants were aliquoted
and stored at −70 °C for further analysis. To verify the identity
of recombinant viruses, the viral genomic RNA for each virus
was sequenced as described above. For all viruses, the titers
were determined by immunocytochemistry as described above.
Transfection and minireplicon assay
Canine footpad keratinocytes at 90% confluence were trans-
fected with 1 μg of pCI-Fwt, pCI-Hwt, pCI-Fop and pCI-Hk in
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(Invitrogen) according the manufacturer's protocol. Photo-
graphs of transfected cells were taken 24 h after transfection.
Canine footpad keratinocytes were infected with the
recombinant vaccinia virus MVA-T7 at an moi of 1.5 at room
temperature for 1 h, and then transfected in 6-well culture dishes
at a confluence of 100% with Lipofectamine 2000 Reagent
(Invitrogen) according to the manufacturer's protocol. Trans-
fections contained the following DNA: 600 ng of peGFP/CAT
(+), 200 ng of pTM-N, 200 ng of pTM-P from A75/17 or A75/
17-K, 0.5 over 500 ng of pTM-L from A75/17, 50 ng of pTM-C
from A75/17 or A75/17-K and 150 ng of pCMV-β-galactosi-
dase. After 4 h, the medium was replaced by William's E
medium 10% FBS. At 24 h after transfection, the cells were
lysed with 0.5 ml of lysis buffer contained in the CAT ELISA kit
(Roche).
Measurement of CAT and β-galactosidase
Cell lysates were diluted 10-fold and assayed for the presence
of CAT and β-galactosidase. The β-galactosidase measurement
was performed at 595 nm using 30 μl of lysates, which was
mixed with 150 μl of CPRG buffer (60 mM Na2HPO4 7·H2O,
40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4, 50 mM β-
mercaptoethanol) and 20 μl of CPRG diluted at 4 mg ml−1 in
H2O. An ELISA kit (Roche) was employed for CAT quantifica-
tion according to the manufacturer's instructions using 200 μl of
lysate. Absorbencies were read at 405 nm and normalized to the
values of β-galactosidase. The results were expressed as CAT
concentration determined from a standard curve.
Western blotting
Total proteins from cell lysates were quantified using the Bio-
Rad Protein Assay based on the Bradford's principle. Proteins
were separated by electrophoresis in a 10% reducing SDS-
polyacrylamide gel and blotted onto nitrocellulose membranes
(Schleicher and Schuell). Western blotting was performed with
different antibodies: D110 anti-NmAb (Hamburger et al., 1991),
anti-β-tubulin mAb, anti-P 4.415 mAb (Martens et al., 1995), an
anti-H antiserum (Cherpillod et al., 1999) and an anti-actin mAb
(Sigma). After incubation with peroxidase-conjugated goat anti-
rabbit immunoglobulin G (DakoCytomation) or goat anti-mouse
immunoglobulin G (Cell Signaling) for 45 min at room
temperature, proteins were visualized by enhanced chemilumi-
nescence (Amersham Biosciences).
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